Search
for
Sort by
Research 181–210 of 187
- Hormonal Therapies for Acne: A Comprehensive Update for Dermatologists
- Alopecia areata
- Recent Approaches in the Treatment of Polycystic Ovary Syndrome: An Update
- Therapeutic Efficacy of Spironolactone for Central Serous Chorioretinopathy
- Phytotherapeutic Interventions using Rodent Models of Hair Loss: Current Research and Future Strategy
- Update on Polycystic Ovary Syndrome
- Medical Treatments for Androgenetic Alopecia
- A comparative study of Aldactone® and Diane® in the treatment of hirsutism
- Epidemiology, diagnosis, and management of polycystic ovary syndrome
- Antiandrogens for the Treatment of Hirsutism: A Systematic Review and Metaanalyses of Randomized Controlled Trials
- A Novel Use of Spironolactone: Treatment of Hirsutism
- Insulin Sensitizers for the Treatment of Hirsutism: A Systematic Review and Metaanalyses of Randomized Controlled Trials
- Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne
- Management of Transgenderism
- Oral spironolactone therapy for female patients with acne, hirsutism or androgenic alopecia
- Comparison of Spironolactone, Flutamide, and Finasteride Efficacy in the Treatment of Hirsutism: A Randomized, Double Blind, Placebo-Controlled Trial1
- Endocrine intervention for transsexuals
- Management of acne
- Dermatologic Manifestations of Polycystic Ovary Syndrome
- Improved Efficacy of Low-Dose Spironolactone and Metformin Combination Than Either Drug Alone in the Management of Women With Polycystic Ovary Syndrome (PCOS): A Six-Month, Open-Label Randomized Study
- Influence of spironolactone treatment on endothelial function in non-obese women with polycystic ovary syndrome
- The effect of spironolactone on genital skin 5α-reductase activity
- Anti‐androgens may protect against severe COVID‐19 outcomes: results from a prospective cohort study of 77 hospitalized men
- Acne in the adult female patient: a practical approach
- ANTIANDROGEN AND HORMONAL TREATMENT OF ACNE
- Hormonal Treatment of Transgender Women with Oral Estradiol
- Spironolactone: An Anti-androgenic and Anti-hypertensive Drug That May Provide Protection Against the Novel Coronavirus (SARS-CoV-2) Induced Acute Respiratory Distress Syndrome (ARDS) in COVID-19
- Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne
- Treatment of female pattern hair loss with the androgen receptor antagonist flutamide
- Oral Contraceptives and Cyproterone Acetate in Female Acne Treatment